Knockout the CCL2 gene with lentivirus or CCR2 inhibitor CCX872 could compromise the infiltration of TAM and MDSC induced by ETV4 and HCC metastasis, which provided a theoretical basis for developing a novel combined immunotherapy strategy for HCC. This evidence concerns the gene CCL2 and hepatocellular carcinoma.